On this page
MYBPC1
myosin binding protein C1
The MYBPC1 gene provides instructions for making the myosin binding protein C, slow skeletal isoform, a protein critical for the development and proper functioning of skeletal muscles. MYBPC1 is a gene that codes for a specific version of myosin binding protein C, primarily found in skeletal muscles.
MYBPC1 is located on the long (q) arm of chromosome 12, at band 12q23.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 12 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The MYBPC1 gene contains the genetic blueprint for myosin binding protein C, slow skeletal isoform. This protein is predominantly expressed in the skeletal muscles, which are responsible for voluntary movement throughout the body. During the development of skeletal muscles, MYBPC1 is active, contributing to the regulation of muscle fibre tension and contraction.
The MYBPC1 protein is known to interact with other vital muscle proteins, such as myosin, actin, and titin. These interactions are fundamental to the structure and function of sarcomeres, the basic contractile units within muscle cells. By contributing to sarcomere stability, MYBPC1 is integral to the mechanical force generation required for muscle movement.
What the gene does
The primary function of the MYBPC1 gene product, myosin binding protein C slow skeletal isoform, is to regulate muscle contraction. It achieves this by interacting with core muscle proteins, including myosin, actin, and titin, within the sarcomeres of skeletal muscle cells. These interactions are essential for the protein's role in governing the tensing of muscle fibres.
Research indicates that MYBPC1 contributes to the overall stability and maintenance of sarcomeres, which are the fundamental structures responsible for muscle contraction. This regulatory role ensures that muscles can generate mechanical force efficiently and effectively. Abnormalities in this protein can therefore disrupt normal muscle function.
Video: Genetics 101
Chromosome location
The MYBPC1 gene is situated on the long arm of chromosome 12, specifically at position 12q23.2. This genomic location specifies its precise address within the human genome, enabling researchers and clinicians to accurately map and study its genetic context.
Protein structure
The MYBPC1 protein comprises 1141 amino acids and features a complex domain architecture. It begins with a Disordered region spanning amino acids 1-51. Following this are multiple Ig-like C2-type domains, including Ig-like C2-type 1 (amino acids 72-144), Ig-like C2-type 2 (amino acids 251-340), Ig-like C2-type 3 (amino acids 341-431), Ig-like C2-type 4 (amino acids 432-520), Ig-like C2-type 5 (amino acids 522-619), Ig-like C2-type 6 (amino acids 837-931), and Ig-like C2-type 7 (amino acids 1047-1141). Additionally, the protein contains three Fibronectin type-III domains: Fibronectin type-III 1 (amino acids 622-721), Fibronectin type-III 2 (amino acids 722-833), and Fibronectin type-III 3 (amino acids 934-1029).
Key variants
Variants within the MYBPC1 gene can impact the structure and function of the myosin binding protein C, slow skeletal isoform. These genetic changes can range from single nucleotide alterations to larger deletions or duplications. The effect of a variant depends on its specific nature and location within the gene, potentially altering protein production, stability, or its ability to interact with other muscle proteins.
Sample of pathogenic variants
7 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.742G>A | p.Glu248Lys | Pathogenic/Likely pathogenic | ★★☆☆ | Myopathy, congenital, with tremor |
c.776T>C | p.Leu259Pro | Pathogenic/Likely pathogenic | ★★☆☆ | Myopathy, congenital, with tremor |
c.788T>G | p.Leu263Arg | Pathogenic | ★★☆☆ | Myopathy, congenital, with tremor |
c.788T>C | p.Leu263Pro | Pathogenic | ★☆☆☆ | not provided |
c.2566T>C | p.Tyr856His | Pathogenic | - | Arthrogryposis, distal, type 1B |
c.706T>C | p.Trp236Arg | Pathogenic | - | Arthrogryposis, distal, type 1B |
c.739T>C | p.Tyr247His | Pathogenic | - | Myopathy, congenital, with tremor |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the MYBPC1 gene are associated with certain inherited conditions that primarily affect muscle function. One such condition is distal arthrogryposis type 1. This disorder is characterised by joint contractures, particularly affecting the hands and feet, which are present from birth. These contractures can restrict joint movement and may require therapeutic intervention.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic MYBPC1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The MYBPC1 gene is recognised within the NHS Genomic Medicine Service, indicating its clinical relevance in the UK. It is included on PanelApp for several conditions, including Arthrogryposis (R83), Congenital myopathy (R81), and Foetal anomalies (R21), all of which are categorised as 'green', signifying strong evidence for gene-disease association. It is also listed under DDG2P.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the role of the MYBPC1 protein in the body?
The MYBPC1 protein, also known as myosin binding protein C, slow skeletal isoform, is primarily found in skeletal muscles. Its main role is to regulate muscle contraction by interacting with other muscle proteins within sarcomeres, contributing to their stability and proper function.
What is distal arthrogryposis type 1?
Distal arthrogryposis type 1 is a genetic condition characterised by joint contractures, meaning restricted movement, primarily affecting the hands and feet. These contractures are typically present from birth and are associated with variants in the MYBPC1 gene.
How is MYBPC1 relevant to genetic screening?
MYBPC1 is relevant to genetic screening, particularly for carrier screening in an autosomal recessive inheritance pattern. This means individuals who carry one altered copy of the gene may not show symptoms but could pass it on to their children, who may be affected if they inherit two altered copies.
References
- Gurnett CA, Desruisseau DM, McCall K. Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1. Human molecular genetics. 2010. PMID: 20045868
- Ackermann MA, Kontrogianni-Konstantopoulos A. Myosin binding protein-C slow: an intricate subfamily of proteins. Journal of biomedicine & biotechnology. 2010. PMID: 20396395
- Weber FE, Vaughan KT, Reinach FC. Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment. European journal of biochemistry. 1993. PMID: 8375400